BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17020655)

  • 21. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.
    Lee MM; Donahoe PK; Silverman BL; Hasegawa T; Hasegawa Y; Gustafson ML; Chang YC; MacLaughlin DT
    N Engl J Med; 1997 May; 336(21):1480-6. PubMed ID: 9154766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered serum profile of inhibin B, Pro-alphaC and anti-Müllerian hormone in prepubertal and pubertal boys with varicocele.
    Trigo RV; Bergadá I; Rey R; Ballerini MG; Bedecarrás P; Bergadá C; Gottlieb S; Campo S
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):758-64. PubMed ID: 15163341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.
    Rey R; Lordereau-Richard I; Carel JC; Barbet P; Cate RL; Roger M; Chaussain JL; Josso N
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1220-6. PubMed ID: 8077315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement.
    Rey RA; Belville C; Nihoul-Fékété C; Michel-Calemard L; Forest MG; Lahlou N; Jaubert F; Mowszowicz I; David M; Saka N; Bouvattier C; Bertrand AM; Lecointre C; Soskin S; Cabrol S; Crosnier H; Léger J; Lortat-Jacob S; Nicolino M; Rabl W; Toledo SP; Baş F; Gompel A; Czernichow P; Josso N
    J Clin Endocrinol Metab; 1999 Feb; 84(2):627-31. PubMed ID: 10022428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.
    Rey R; al-Attar L; Louis F; Jaubert F; Barbet P; Nihoul-Fékété C; Chaussain JL; Josso N
    Am J Pathol; 1996 May; 148(5):1689-98. PubMed ID: 8623936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-Müllerian hormone (AMH) measurements in the assessment of testicular function in prepubertal boys and in sexual differentiation disorders].
    Szarras-Czapnik M; Gajewska M; Ksiazyk J; Janas R; Ginalska-Malinowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):195-9. PubMed ID: 17020655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antimullerian hormone in clinical human applications].
    Josso N; Rey R
    Contracept Fertil Sex; 1994 Oct; 22(10):661-3. PubMed ID: 7804385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of seminiferous tubule function (anti-müllerian hormone).
    Rey R
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Sep; 14(3):399-408. PubMed ID: 11097782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIS/AMH in the assessment of cryptorchidism and intersex conditions.
    Lee MM; Misra M; Donahoe PK; MacLaughlin DT
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):91-8. PubMed ID: 14656481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Müllerian hormone receptor defect.
    di Clemente N; Belville C
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):599-610. PubMed ID: 17161334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications.
    Josso N; Picard JY; Rey R; di Clemente N
    Pediatr Endocrinol Rev; 2006 Jun; 3(4):347-58. PubMed ID: 16816803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Müllerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis.
    Edelsztein NY; Grinspon RP; Schteingart HF; Rey RA
    Int J Pediatr Endocrinol; 2016; 2016():20. PubMed ID: 27799946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to evaluate gonadal function in the cryptorchid boy. Lessons from new testicular markers.
    Rey R
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):357-64. PubMed ID: 12705358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-Mullerian hormone: a gonadal hormone with multiple diagnostics resources].
    Vladimirov Ia; Tacheva D; Blagoeva V; Ivanova A; Kalinov K; Vasileva S; Stankova D
    Akush Ginekol (Sofiia); 2005; 44(7):37-40. PubMed ID: 16544718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Müllerian hormone, testicular descent and cryptorchidism.
    Rey RA; Grinspon RP
    Front Endocrinol (Lausanne); 2024; 15():1361032. PubMed ID: 38501100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.
    Young J; Rey R; Schaison G; Chanson P
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):51-4. PubMed ID: 14656476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges.
    Hagen CP; Aksglaede L; Sørensen K; Mouritsen A; Juul A
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():525-8. PubMed ID: 22423510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism.
    Grinspon RP; Rey RA
    Horm Res Paediatr; 2010; 73(2):81-92. PubMed ID: 20190544
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.